Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.53), $0.06 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.